A Study Of Metabolomics Of Sinonasal Squamous Cell Carcinoma

Overview

About this study

The purpose of this study is to define the metabolomic profile of sinonasal squamous cell carcinoma in 10 tumors as pilot data compared to normal controls undergoing skull base surgery. Identify targets for future directed metabolomics in a larger cohort of sinonasal cancers. Identify possible targetable pathways for possible new therapeutics in sinonasal cancer care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age >18 years .

  • Newly diagnosed sinonasal squamous cell carcinoma.

  • Patients with no sinonasal disease undergoing skull base surgery (normal controls) 

 

Exclusion Criteria:

  • Age <18 years.

  • Patients who are unable to provide written consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/23/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Eide

Open for enrollment

Contact information:

Jacob Eide

(507) 284-2544

Eide.Jacob@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597195

Mayo Clinic Footer